Cell and Gene Therapy | Novartis

A scientist working in a laboratory at a Novartis location

We are reimagining medicine to power breakthrough innovation in cell and gene therapy

Novartis Stein, Switzerland

New cell and gene facility inaugurated in Switzerland

Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.

Learn More

Cell and gene scientists working in a laboratory

Delivering on the promise of cell and gene therapy for patients

New advances in cell and gene therapies offer the potential to transform medicine. They create an inflection point in our ability to treat and even potentially cure many intractable illnesses.

Activated T-cells (shown in blue) attack and destroy a cancer cell.

What is cell and gene therapy?

An introduction to cell and gene therapy.

Learn More

A image showing scientists working in a laboratory

A new era of medicine

Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life.

Learn More

Image of a T-cell attacking a cancerous cell

Key focus areas

Currently, there are three key focus areas for development of transformative cell and gene therapies at Novartis: AAV-based therapies, CAR-T cell therapies and CRISPR-based technologies.

Learn More

A Cell Processing Specialist at work in Novartis’ new cell and gene production facility in Stein, Switzerland.

Hardwiring the future

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Read More

Learn more about the power of cell and gene therapies

Cell & Gene-related media releases


Be the first to comment

Leave a Reply

Your email address will not be published.